Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAllergic reactions to tirzepatide are uncommon, but knowing the signs matters. Symptoms range from mild skin reactions at the injection site to, very rarely, a serious systemic response. This page explains what tirzepatide allergy symptoms look like, how to tell them apart from ordinary side effects, and when to seek help urgently. As a prescription-only medicine, tirzepatide (sold in the UK as Mounjaro) is only suitable for some people — and a prescriber's assessment is the right place to raise any allergy concerns before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people starting tirzepatide notice gastrointestinal symptoms (nausea, loose stools, a feeling of fullness) and these are well-recognised, expected responses as the body adjusts. An allergic reaction is a different thing. It involves the immune system reacting to the medicine itself or one of its excipients, and it usually has a distinct pattern.
Localised reactions at the injection site (a small red welt, some itching, or mild swelling that appears within minutes of injecting and fades over an hour or two) are common and generally not true allergy. If the redness is spreading beyond the injection area, persists for more than a day, or is accompanied by symptoms elsewhere on the body, that warrants a call to your prescriber rather than a wait-and-see approach.
Signs that suggest a genuine allergic response include widespread hives (raised, itchy bumps across the skin), facial swelling, swelling of the lips or tongue, and a rash that spreads rapidly. These are not part of the expected GI-led side-effect profile described in the NHS's tirzepatide medicines page and should prompt contact with a clinician. If you are uncertain whether what you are experiencing is expected or not, the full side-effect picture for Mounjaro is a useful reference point.
Anaphylaxis is rare with tirzepatide, but it is a medical emergency when it occurs. It tends to develop within minutes to an hour of injection — sometimes while you are still sitting at the kitchen table after your weekly dose.
The warning signs include: sudden difficulty breathing or a tight, wheezy chest; swelling of the throat that makes swallowing or speaking difficult; a rapid or weak pulse; dizziness or collapse; pale or blotchy skin; and an intense sense that something is badly wrong. Any combination of these symptoms, especially alongside skin changes or a recent injection, means calling 999 straight away. Do not drive yourself. Do not wait to phone a pharmacy or GP first.
If you carry an adrenaline auto-injector for another known allergy, use it while someone calls the emergency services. Anaphylaxis to a GLP-1 medicine has been documented in the medical literature, and the Mounjaro SmPC lists hypersensitivity reactions (including anaphylaxis and angioedema) among the adverse effects requiring immediate medical attention. More detail on recognising hypersensitivity is covered on our dedicated tirzepatide allergy page.
Yes, and this is where things can get confusing. Two conditions in particular can present with abdominal symptoms that people sometimes attribute to a reaction: pancreatitis and gallbladder problems.
Pancreatitis typically causes severe, persistent pain in the upper abdomen that radiates to the back, quite different from the nausea and bloating of a standard GLP-1 adjustment period. The MHRA highlighted acute pancreatitis as a known, if infrequent, serious risk in its Yellow Card safety reporting system, and issued a Drug Safety Update on GLP-1 medicines in January 2026 specifically flagging this. Separately, gallbladder issues can cause sharp pain in the upper right abdomen, sometimes with fever. Neither of these is an allergic reaction, but both need prompt medical attention. You can read more about Mounjaro pancreas symptoms and gallbladder symptoms on their own pages.
Injection-site reactions (redness, bruising, a small lump) are also frequently mistaken for allergy. Rotating sites (abdomen, thigh, upper arm) and using a fresh needle each time reduces these. If a lump persists for more than a week or grows, let your prescriber know.
The action depends entirely on what you are experiencing. For a suspected anaphylaxis: 999, immediately. For signs of a serious but non-emergency allergic response (spreading hives, facial swelling without airway involvement): contact your GP or call 111 the same day, and stop your next planned dose until you have spoken to a clinician. For mild injection-site reactions that are clearly local and settling: note them, mention them at your next clinical review, and continue as normal unless they worsen.
Any suspected side effect from a prescription medicine can be reported directly to the MHRA via the Yellow Card scheme, this is separate from getting personal medical advice, but it contributes to ongoing safety monitoring for tirzepatide, which still carries a Black Triangle (▼) status indicating active post-market surveillance.
If you are thinking about starting tirzepatide and have a history of drug allergies or hypersensitivity reactions, that conversation belongs in the consultation. You can also explore what treatment with Mounjaro typically involves before making any decisions. Our prescribers at nume review every consultation personally (a real clinician reads your answers, not software) and allergy history is part of that clinical picture. When you are ready, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.